Clinical Trial Update: Inhaled Ondansetron & Dyspnea [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial evaluating inhaled ondansetron for dyspnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspnea

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: McGill University | Conditions: Dyspnea | EARLY_Phase 1 | Status: COMPLETED